葛兰素史克与阿纳普蒂生物就十年期Jemperli许可协议对簿公堂
GSK subsidiary Tesaro and AnaptysBio are at legal loggerheads over a licensing pact concerning the cancer drug Jemperli that dates back to 2014. On Thursday, GS...
GSK subsidiary Tesaro and AnaptysBio are at legal loggerheads over a licensing pact concerning the cancer drug Jemperli that dates back to 2014.
On Thursday, GSK said Tesaro has filed a ...